Challenges in the Primary Care of Depression: A Patient Huddle Activity
Psychiatry
Curriculum:
Derail Depression: Treatment On Track
Derail Depression: Treatment On Track
Launch Date:
November 21, 2019
November 21, 2019
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Psychiatrists; primary care physicians; other healthcare professionals who treat patients with major depressive disorder (MDD)
Relevant Terms:
Major depressive disorder; primary care; collaborative care model; electronic health record; measurement-based care; PHQ-9
Caroline Thomas Barnhart, LCSW
Director of Behavioral Health
Penn Medicine Lancaster General Health
Lancaster, PA
Caroline Thomas Barnhart is the Director of the Behavioral Health Service Line at Penn Medicine Lancaster General Health. She is leading the effort to integrate behavioral health across the continuum of care, improving care delivery for patients with mental health and substance use disorders.She is a Licensed Clinical Social Worker who earned her Master's degree in Clinical Social Work from Bryn Mawr College and her Bachelor's degree in Social Work from Millersville University. She completed a Certificiate in Integrated Behavioral Health and Primary Care through the University of Michigan.
James Hawthorne III, MD
Assistant Professor of Psychiatry
University of Kentucky College of Medicine
Lexington, KY
James Hawthorne III, MD is an assistant professor of psychiatry of the University of Kentucky College of Medicine in Lexington, Kentucky. Currently, he is the Associate Program Director for the Psychiatry Residency Program and the Program Director for the Addiction Medicine Fellowship.
Dr. Hawthorne received his medical degree and completed a residency at the University of Kentucky College of Medicine, Lexington. His interests include addiction treatment, mood disorders, as well as resident and medical student education.
| 1. | Identify patients whose MDD is not diagnosed or whose MDD is not being adequately treated in the primary care setting. | 2. | Create a comprehensive plan to work with patients in managing their MDD. |
| 3. | Evaluate specific patient cases to determine when mental health consult is necessary. | 4. | Design a collaborative plan to work with specialists in managing patients with complicated or difficult-to-treat MDD. |
| 5. | Integrate measurement-based tools available in the EHR into the management of patients with MDD. |
| 1. | Identify patients whose MDD is not diagnosed or whose MDD is not being adequately treated in the primary care setting. |
| 2. | Create a comprehensive plan to work with patients in managing their MDD. |
| 3. | Evaluate specific patient cases to determine when mental health consult is necessary. |
| 4. | Design a collaborative plan to work with specialists in managing patients with complicated or difficult-to-treat MDD. |
| 5. | Integrate measurement-based tools available in the EHR into the management of patients with MDD. |
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint
providership of the University of Kentucky College of Medicine and DKBmed. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuation medical education for physicians.
providership of the University of Kentucky College of Medicine and DKBmed. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuation medical education for physicians.
The University of Kentucky College of Medicine designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The University of Kentucky College of Medicine presents this activity for educational purposes only.
Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
Other
UK Healthcare CECentral certifies this activity for 0.5 hour of participation.
UK Healthcare CECentral certifies this activity for 0.5 hour of participation.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented
by the Postgraduate Institute for Medicine, the University of Kentucky, and DKBmed, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
by the Postgraduate Institute for Medicine, the University of Kentucky, and DKBmed, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5
contact hours. Designated for 0.4 contact hours of pharmacology credit for Advanced Practice Registered Nurses.
contact hours. Designated for 0.4 contact hours of pharmacology credit for Advanced Practice Registered Nurses.
Social Worker Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 0.5 clinical continuing education credits.
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 0.5 clinical continuing education credits.
Target Audience
This activity is intended for health care professionals and social workers involved with the management or treatment of patients with major depressive disorder (MDD).
This activity is intended for health care professionals and social workers involved with the management or treatment of patients with major depressive disorder (MDD).
Educational Support
This activity is supported by an independent medical education grant from Otsuka Pharmaceuticals, Inc., Takeda Pharmaceuticals U.S.A., Inc., and Lundbeck.
This activity is supported by an independent medical education grant from Otsuka Pharmaceuticals, Inc., Takeda Pharmaceuticals U.S.A., Inc., and Lundbeck.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Planners and Managers
Planning committee members from Penn Medicine Lancaster General Health, Caroline Thomas Barnhart, LCSW and the University of Kentucky College of Medicine, James Hawthorne III, MD have nothing to disclose.
The PIM planners and managers have nothing to disclose.
The following DKB planners and managers Dean Beals, Stan Pogroszewski, Rachel Deerr, and Lesley Simon, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Estimated time to complete activity: 0.5 hours
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above. |
